These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 24601489)

  • 1. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
    Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
    ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
    Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
    Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Polymyxin-Like Antibiotics.
    Velkov T; Roberts KD
    Adv Exp Med Biol; 2019; 1145():343-362. PubMed ID: 31364086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History, Chemistry and Antibacterial Spectrum.
    Velkov T; Thompson PE; Azad MAK; Roberts KD; Bergen PJ
    Adv Exp Med Biol; 2019; 1145():15-36. PubMed ID: 31364069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' Polymyxins.
    Paterson DL; Bonomo RA
    Adv Exp Med Biol; 2019; 1145():9-13. PubMed ID: 31364068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rediscovering the octapeptins.
    Velkov T; Roberts KD; Li J
    Nat Prod Rep; 2017 Mar; 34(3):295-309. PubMed ID: 28180225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxins: a new hope in combating Gram-negative superbugs?
    Velkov T; Roberts KD; Thompson PE; Li J
    Future Med Chem; 2016 Jun; 8(10):1017-25. PubMed ID: 27328129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure--activity relationships of polymyxin antibiotics.
    Velkov T; Thompson PE; Nation RL; Li J
    J Med Chem; 2010 Mar; 53(5):1898-916. PubMed ID: 19874036
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
    Brown P; Dawson MJ
    J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the penetration of antimicrobial polymyxin lipopeptides into gram-negative bacteria.
    Deris ZZ; Swarbrick JD; Roberts KD; Azad MA; Akter J; Horne AS; Nation RL; Rogers KL; Thompson PE; Velkov T; Li J
    Bioconjug Chem; 2014 Apr; 25(4):750-60. PubMed ID: 24635310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
    Vaara M
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical translation of polymyxin-based combination therapy: Facts, challenges and future opportunities.
    Zhang X; Guo F; Shao H; Zheng X
    J Infect; 2017 Feb; 74(2):118-130. PubMed ID: 27998750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria.
    Velkov T; Gallardo-Godoy A; Swarbrick JD; Blaskovich MAT; Elliott AG; Han M; Thompson PE; Roberts KD; Huang JX; Becker B; Butler MS; Lash LH; Henriques ST; Nation RL; Sivanesan S; Sani MA; Separovic F; Mertens H; Bulach D; Seemann T; Owen J; Li J; Cooper MA
    Cell Chem Biol; 2018 Apr; 25(4):380-391.e5. PubMed ID: 29396290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin antibiotics for gram-negative infections.
    Arnold TM; Forrest GN; Messmer KJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):819-26. PubMed ID: 17420197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.
    Poirel L; Jayol A; Nordmann P
    Clin Microbiol Rev; 2017 Apr; 30(2):557-596. PubMed ID: 28275006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens.
    Roberts KD; Zhu Y; Azad MAK; Han ML; Wang J; Wang L; Yu HH; Horne AS; Pinson JA; Rudd D; Voelcker NH; Patil NA; Zhao J; Jiang X; Lu J; Chen K; Lomovskaya O; Hecker SJ; Thompson PE; Nation RL; Dudley MN; Griffith DC; Velkov T; Li J
    Nat Commun; 2022 Mar; 13(1):1625. PubMed ID: 35338128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
    Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
    Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.